Enhancement of the arthus reaction and suppression of delayed type hypersensitivity (DTH) by pluronic F-68, a detergent frequently used to prepare perfluorocarbon emulsions

International Journal of Immunopharmacology

Volumn 11, Issue 3, 1989, Pages 241-248

  Triolo, Anthony J ^a   Osterholm, Jewell L ^a   Kratky, Martha T ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; FLUOROCARBON; LEVAMISOLE; POLOXAMER;

ANIMAL EXPERIMENT; ARTHUS PHENOMENON; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ARTHUS REACTION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HYPERSENSITIVITY, DELAYED; LEVAMISOLE; MICE; POLOXALENE; POLYETHYLENE GLYCOLS; SUPPORT, NON-U.S. GOV'T;

EID: 0024524084     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(89)90161-6     Document Type: Article

References (34)

1. Homeostatic control of antibody response: a model based on the recognition of cell-associated antibody by regulatory T-cells
2. Immunopathology
3. Focal cerebral ischemia: reduction in size of infarcts by ventriculosubarachnoid perfusion with fluorocarbon emulsion
4. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function
5. Can fluorocarbon emulsions be used as artificial blood?
6. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure
7. Delayed hypersensitivity in the mouse
8. Potential uses of artificial blood substitutes
9. Surfactants and perfluorochemical emulsions for use in blood replacement preparations
10. Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon
11. Fluosol-DA as a red-cell substitute in acute anemia
12. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo
13. Effect of exchange transfusion with Fluosol-DA 20% on splenic distribution and immunocompetence of rat lymphocytes
14. Regulation of delayed-type hypersensitivity. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice
15. Regulation of delayed-type hypersensitivity. II. Specific suppressor factor for delayed-type hypersensitivity to sheep erythrocytes in mice
16. Effects of potential blood substitutes (Perfluorochemicals) on rat liver and spleen
17. Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells
18. Feedback inhibition of specifically sensitized lymphocytes
19. Some morphologic effects of “inert” particulate loading on hemopoietic elements in mice
20. Further studies on intake and retention of PFC substance of Fluosol-DA in RES in humans
21. Effect of Fluosol DA 20% on antibody response to type 3 pneumococcal polysaccharide in rats
22. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) Part II. Human cerebral blood flow
23. Perfluorochemicals. Morphologic changes in infused liver, spleen, lung and kidney of rabbits
24. Fluoro carbon emulsion as the transporter of oxygen
25. Severe cerebral ischemia treatment by ventriculosubarachnoid perfusion with an oxygenated fluorocarbon emulsion
26. Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity
27. Some long-term effects of exchange transfusion with fluorocarbon emulsions in Macaque monkeys
28. The effect of Levamisole on cell-mediated immunity and suppressor cell function
29. Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity
30. Levamisole in the modulation of the immune response: the current experimental and clinical state
31. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer
32. The mechanisms and mediators of cellular hypersensitivity
33. Drugs that increase delayed hypersensitivity reactions
34. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis